Skip to main content

Genaissance to Provide Scrapie Genotyping for Cyprus

NEW YORK, Aug. 23 (GenomeWeb News) - Genaissance Pharmaceuticals will provide scrapie genotyping services to Biotronics of Cyprus, Genaissance said today.

 

Biotronics has been awarded a contract by the Cypriot government, which derives from a mandate by the European Union for establishing a breeding program in sheep that confers resistance to scrapie.

 

Under the contract, Genaissance will analyze at least 100,000 samples, collected by Biotronics, over approximately a three-month period.

 

Earlier this month, Genaissance won a similar contract to provide scrapie genotyping for Greece.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.